CDKN2B-AS1 and non-small cell lung carcinoma: Moreover, analysis of existent association with both clinicopathological features and prognosis were examined in order to determine whether lncRNA ANRIL could be considered a potential prognostic factor for the prediction of clinical outcomes in NSCLC patients.